|
π
|
CCL2 in the Circulation Predicts LongβTerm Progression of Interstitial Lung Disease in Patients With Early Systemic Sclerosis: Data From Two Independent Cohorts
14 auth.
Minghua Wu,
M. Baron,
C. Pedroza,
G. Salazar,
J. Ying,
J. Charles,
S. Agarwal,
M. Hudson,
J. Pope,
Xiaodong Zhou,
...
J. Reveille,
M. Fritzler,
M. Mayes,
S. Assassi
|
6 |
2017 |
6
π
|
|
π¦
|
Antinuclear antibody-negative systemic sclerosis.
34 auth.
G. Salazar,
S. Assassi,
F. Wigley,
L. Hummers,
J. Varga,
M. Hinchcliff,
D. Khanna,
E. Schiopu,
K. Phillips,
D. Furst,
V. Steen,
M. Baron,
M. Hudson,
S. Taillefer,
J. Pope,
...
N. Jones,
P. Docherty,
N. Khalidi,
D. Robinson,
R. Simms,
R. Silver,
T. Frech,
B. Fessler,
J. Molitor,
M. Fritzler,
B. Segal,
Firas Al-Kassab,
Marilyn Perry,
Jeremy Yang,
S. Zamanian,
J. Reveille,
F. Arnett,
C. Pedroza,
M. Mayes
|
6 |
2015 |
6
π¦
|
|
π
|
Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis
11 auth.
Minghua Wu,
B. Skaug,
Xiongjie Bi,
Tingting W. Mills,
G. Salazar,
Xiaodong Zhou,
...
J. Reveille,
S. Agarwal,
M. Blackburn,
M. Mayes,
S. Assassi
|
6 |
2019 |
6
π
|
|
π¦
|
KL-6 But Not CCL-18 Is a Predictor of Early Progression in Systemic Sclerosis-related Interstitial Lung Disease
8 auth.
G. Salazar,
M. Kuwana,
Minghua Wu,
R. Estrada-Y.-Martin,
J. Ying,
J. Charles,
...
M. Mayes,
S. Assassi
|
6 |
2018 |
6
π¦
|
|
π
|
The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts
40 auth.
D. Dougherty,
L. Kwakkenbos,
M. Carrier,
G. Salazar,
S. Assassi,
M. Baron,
S. Bartlett,
D. Furst,
Karen Gottesman,
F. V. D. van den Hoogen,
V. Malcarne,
L. Mouthon,
W. Nielson,
S. Poiraudeau,
M. Sauve,
...
G. Boire,
Alessandra Bruns,
L. Chung,
C. Denton,
J. Dunne,
P. Fortin,
T. Frech,
Anna Gill,
J. Gordon,
A. Herrick,
M. Hinchcliff,
M. Hudson,
S. Johnson,
N. Jones,
S. Kafaja,
M. LarchΓ©,
J. Manning,
J. Pope,
R. Spiera,
V. Steen,
E. Sutton,
C. Thorne,
P. Wilcox,
B. Thombs,
M. Mayes
|
5 |
2018 |
5
π
|
|
π
|
Long noncoding RNA H19X is a key mediator of TGFΞ² driven fibrosis.
23 auth.
E. Pachera,
S. Assassi,
G. Salazar,
M. Stellato,
F. Renoux,
A. Wunderlin,
P. BΕyszczuk,
R. Lafyatis,
F. Kurreeman,
J. D. de Vries-Bouwstra,
...
T. Messemaker,
C. Feghali-Bostwick,
G. Rogler,
W. T. van Haaften,
G. Dijkstra,
F. Oakley,
M. Calcagni,
J. Schniering,
B. Maurer,
J. Distler,
G. Kania,
M. Frank-Bertoncelj,
O. Distler
|
5 |
2020 |
5
π
|
|
π
|
Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis
7 auth.
J. Pauling,
G. Salazar,
Hui Lu,
Z. Betteridge,
S. Assassi,
M. Mayes,
...
N. McHugh
|
5 |
2018 |
5
π
|
|
π
|
Autoantibodies to Dense Fine Speckles in Pediatric Diseases and Controls
18 auth.
H. Schmeling,
M. Mahler,
D. Levy,
K. Moore,
A. Stevens,
James P. Wick,
Jacob D McMillan,
G. Horneff,
S. Assassi,
J. Charles,
...
G. Salazar,
M. Mayes,
E. Silverman,
Marissa Klien-Gitelman,
Tzelan Lee,
H. Brunner,
A. Reed,
M. Fritzler
|
5 |
2015 |
5
π
|
